THE CASE AGAINST, as I see it. The Product. How well does it...

THE CASE AGAINST, as I see it.

The Product.  How well does it work?  "Strong clinical evidence" is a long way from 'overwhelming evidence', or 'proof'.
Originally CT results were intended to be revealed early this year.  We haven't been shown even interim data.  At best this is just from inability to get participants.
Purchasing interest has been very disappointing.  V2 hasn't been good enough to get a deal.

Cash Position.  Without a deal in the short term which includes significant cash up front a CR is likely (in conjunction with consolidation), but who would be interested without 'overwhelming evidence' of likely business success.  Monsour stuffed up the last one imo ruining s/h value in the process for far less than what could have been gained.  
I for one didn't participate and I doubt many of you folk will in the next without extreme confidence.  Monsour and the rest won't pick up the tab.

Management & Board.  Give me the impression of a boys club with a hobby, trying to market a product for women.  Our competitor is by women for women.  (Is the girl who won the award still with us?)
Mistrust Monsour's commitment, dominant holding, decision making.  Is the asb being packaged with pericoach simply because he wants to be rid of it?  Said he thinks we'll get a deal in the very near term - if there's not within 6 months that will confirm for me my mistrust is well founded.  
Overall I don't trust them - lack of concise info, past performance with asb, options, misjudgements, language used with us.  And too slow with pericoach progress, putting it all at risk from current and potential competitors.

Your opinions on this are welcome.